Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number
2023-07-10 20:18
Wegovy Maker Sues US Pharmacy to Block Knock-Off
Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the
2023-07-07 08:25
Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:53
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
2023-06-30 19:19
Last Taboo for Hit Obesity Drug Is Asking When to Stop
Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question
2023-06-30 12:18
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:21
The Race to Develop Weight-Loss Pills Has Some Drugmakers Falling Behind
Obesity shots like Wegovy are already a cultural phenomenon. Now it’s looking like pill forms of the drugs
2023-06-27 06:00
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:23
Pfizer Halts Early-Stage Obesity Drug on Safety Concerns
Pfizer Inc. is halting early development of a weight-loss drug on safety concerns, raising investor anxiety about another
2023-06-26 21:55
Eli Lilly’s Experimental Weight-Loss Pill Show Rapid Results in Study
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the
2023-06-24 05:55
Carson Block’s Latest Short Bet Is Burned by Novartis M&A Deal
Carson Block’s Muddy Waters wager against a hedge-fund favorite, Chinook Therapeutics Inc., took a hit Monday after Novartis
2023-06-12 23:46
Credit Suisse's Exit From Stock Benchmark Shows Fading Heft of Swiss Financials
Credit Suisse Group AG’s imminent exit from the Swiss Market Index is symbolic of the decreasing importance of
2023-06-12 16:20